Insiders Adverum Biotechnologies, Inc.

Equities

ADVM

US00773U2078

Market Closed - Nasdaq Other stock markets 16:00:00 2024-05-09 EDT			5-day change	1st Jan Change
9.61 ^USD	-2.04%		-3.90%	+27.66%

04-30	HC Wainwright Starts Adverum Biotechnologies With Buy Rating, $30 Price Target	MT
04-29	Mizuho Adjusts Price Target on Adverum Biotechnologies to $22 From $40 After Model Update, Maintains Buy Rating	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Adverum Biotechnologies, Inc. Appoints Romuald Corbau as Chief Scientific Officer and Member of Executive Committee	01-29	CI
Adverum Biotechnologies, Inc. Appoints C. David Nicholson to the Board of Directors	11-06	CI
Adverum Biotechnologies Names R. Andrew Ramelmeier Chief Technology Officer	23-08-22	MT
Adverum Biotechnologies, Inc. Appoints R. Andrew Andy Ramelmeier as Chief Technology Officer	23-08-21	CI
Insider Buy: Adverum Biotechnologies	23-06-09	MT
Adverum Biotechnologies, Inc. Announces Resignation of Richard Beckman as Chief Medical Officer	23-05-25	CI
Adverum Biotechnologies, Inc. Appoints Linda Rubinstein as Chief Financial Officer	22-12-13	CI
Adverum Biotechnologies, Inc. Announces Executive Changes	22-06-06	CI
Adverum Biotechnologies, Inc. Announces Board Appointments	22-03-17	CI
Adverum Biotechnologies Names Chief Medical Officer	22-02-07	MT
Adverum Biotechnologies, Inc. Appoints Richard Beckman M.D. as Chief Medical Officer	22-02-07	CI
Adverum Biotechnologies Names Star Seyedkazemi Chief Development Officer	22-01-06	MT
Adverum Biotechnologies Appoints Star Seyedkazemi, Pharm.D. as Chief Development Officer	22-01-06	CI
Adverum Biotechnologies, Inc. Announces Board Changes	21-12-21	CI
Adverum Biotechnologies, Inc Announces Appointment of Rupert D’Souza as Chief Financial Officer	21-12-06	CI
Adverum Biotechnologies, Inc. Announces to Cease Jack Thrift, Interim Principal Financial Officer and Principal Accounting Officer	21-11-19	CI
Insider Sell: Adverum Biotechnologies	21-11-17	MT
Adverum Biotechnologies, Inc. Announces Executive Changes	21-10-22	CI
Adverum Biotechnologies, Inc. Announces Executive Changes	21-09-09	CI
Adverum Biotechnologies, Inc Appoints Jim Wang as Senior Vice President, Head of Regulatory Affairs	21-08-23	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Adverum Biotechnologies, Inc.

Equities

ADVM

US00773U2078

Insiders

Filters